Chemokine Co-receptor 5 Antagonists [MoA] - N0000175445

Pharmacologic Class Information

Pharmacologic Code N0000175445
Pharmacologic Name Chemokine Co-receptor 5 Antagonists
Pharmacologic Uses
  • CCR5 co-receptor antagonist
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Chemokine Co-receptor 5 Antagonists

The following table contains 7 products whose active ingredient are classified under the same pharmacologic class Chemokine Co-receptor 5 Antagonists [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
31722-579Maraviroc Non-Proprietary Name: MaravirocTablet, Film CoatedOralCamber Pharmaceuticals, Inc.ACTIVE
31722-580Maraviroc Non-Proprietary Name: MaravirocTablet, Film CoatedOralCamber Pharmaceuticals, Inc.ACTIVE
49702-223Selzentry Non-Proprietary Name: MaravirocTablet, Film CoatedOralViiv Healthcare CompanyACTIVE
49702-224Selzentry Non-Proprietary Name: MaravirocTablet, Film CoatedOralViiv Healthcare CompanyACTIVE
49702-233Selzentry Non-Proprietary Name: MaravirocTablet, Film CoatedOralViiv Healthcare CompanyACTIVE
49702-235Selzentry Non-Proprietary Name: MaravirocTablet, Film CoatedOralViiv Healthcare CompanyACTIVE
49702-237Selzentry Non-Proprietary Name: MaravirocSolutionOralViiv Healthcare CompanyACTIVE